BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23077082)

  • 1. Long-range transcriptional regulation of breast cancer genes.
    Betts JA; French JD; Brown MA; Edwards SL
    Genes Chromosomes Cancer; 2013 Feb; 52(2):113-25. PubMed ID: 23077082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in analysis of transcriptional regulatory networks.
    Kim TM; Park PJ
    Wiley Interdiscip Rev Syst Biol Med; 2011; 3(1):21-35. PubMed ID: 21069662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide prediction of transcriptional regulatory elements of human promoters using gene expression and promoter analysis data.
    Kim SY; Kim Y
    BMC Bioinformatics; 2006 Jul; 7():330. PubMed ID: 16817975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PEA3, AP-1, and a unique repetitive sequence all are involved in transcriptional regulation of the breast cancer-associated gene, mammaglobin.
    Hesselbrock DR; Kurpios N; Hassell JA; Watson MA; Fleming TP
    Breast Cancer Res Treat; 2005 Feb; 89(3):289-96. PubMed ID: 15754128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive and negative transcriptional regulation of aromatase expression in human breast cancer tissue.
    Chen S; Ye J; Kijima I; Kinoshita Y; Zhou D
    J Steroid Biochem Mol Biol; 2005 May; 95(1-5):17-23. PubMed ID: 15955695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oct-4B isoform is differentially expressed in breast cancer cells: hypermethylation of regulatory elements of Oct-4A suggests an alternative promoter and transcriptional start site for Oct-4B transcription.
    Wang Y; Meng L; Hu H; Zhang Y; Zhao C; Li Q; Shi F; Wang X; Lin A
    Biosci Rep; 2011 Apr; 31(2):109-15. PubMed ID: 20433421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inherited predisposition to breast cancer: after the BRCA1 and BRCA2 genes, what next?].
    Bonadona V; Lasset C
    Bull Cancer; 2003 Jul; 90(7):587-94. PubMed ID: 12957799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenic pathways in hereditary and sporadic breast cancer.
    Kenemans P; Verstraeten RA; Verheijen RH
    Maturitas; 2004 Sep; 49(1):34-43. PubMed ID: 15351094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Risk assessment for familial occurrence of breast cancer].
    Chang-Claude J; Becher H; Hamann U; Schroeder-Kurth T
    Zentralbl Gynakol; 1995; 117(8):423-34. PubMed ID: 7571905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers.
    Walker LC; Waddell N; Ten Haaf A; ; Grimmond S; Spurdle AB
    Breast Cancer Res Treat; 2008 Nov; 112(2):229-36. PubMed ID: 18095154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cells.
    Wang P; Branch DR; Bali M; Schultz GA; Goss PE; Jin T
    Biochem J; 2003 Oct; 375(Pt 1):199-205. PubMed ID: 12841847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
    Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP
    Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Models of genetic susceptibility to breast cancer.
    Antoniou AC; Easton DF
    Oncogene; 2006 Sep; 25(43):5898-905. PubMed ID: 16998504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative bioinformatics analysis of transcriptional regulatory programs in breast cancer cells.
    Niida A; Smith AD; Imoto S; Tsutsumi S; Aburatani H; Zhang MQ; Akiyama T
    BMC Bioinformatics; 2008 Sep; 9():404. PubMed ID: 18823535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MUC1 gene overexpressed in breast cancer: structure and transcriptional activity of the MUC1 promoter and role of estrogen receptor alpha (ERalpha) in regulation of the MUC1 gene expression.
    Zaretsky JZ; Barnea I; Aylon Y; Gorivodsky M; Wreschner DH; Keydar I
    Mol Cancer; 2006 Nov; 5():57. PubMed ID: 17083744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in molecular genetics of breast cancer.
    Pavelić K; Gall-Troselj K
    J Mol Med (Berl); 2001 Oct; 79(10):566-73. PubMed ID: 11692153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and genomic analysis modeling of germline c-MYC overexpression and cancer susceptibility.
    Solé X; Hernández P; de Heredia ML; Armengol L; Rodríguez-Santiago B; Gómez L; Maxwell CA; Aguiló F; Condom E; Abril J; Pérez-Jurado L; Estivill X; Nunes V; Capellá G; Gruber SB; Moreno V; Pujana MA
    BMC Genomics; 2008 Jan; 9():12. PubMed ID: 18190704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer metastasis-associated genes: prognostic significance and therapeutic implications.
    Moustafa AS; Nicolson GL
    Oncol Res; 1997; 9(10):505-25. PubMed ID: 9507529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of altered cis-regulatory elements in human disease.
    Mathelier A; Shi W; Wasserman WW
    Trends Genet; 2015 Feb; 31(2):67-76. PubMed ID: 25637093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical and molecular diagnosis of inherited breast-ovarian cancer].
    Chompret A
    J Gynecol Obstet Biol Reprod (Paris); 2003 Apr; 32(2):101-19. PubMed ID: 12717301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.